



Title of thesis: ASSOCIATION BETWEEN C-REACITVE PROTEIN AND 
SERUM 25-HYDROXYVITAMIN D: A NEGATIVE ACUTE 
PHASE REACTANT 
 




Thesis directed by:  Dr. Sunmin Lee, ScD, MPH 
Department of Epidemiology and Biostatistics 
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Methods:  Multiple linear regression analysis was utilized to assess the association 
between CRP and 25-OH-vitamin D in 1,043 patients with acute and chronic diseases and 
normal volunteers. 
Results:  After adjusting for confounding factors, the association between CRP and 25-
OH-vitamin D was statistically significant.  Class of diagnosis did not modify this 
association.  
Conclusions:  25-OH-vitamin D is demonstrated to be a negative acute phase reactant in 
this group of patients; Therefore, it is not an accurate marker of vitamin D status in the 
setting of inflammation.  These findings support that 25-OH-vitamin D should be 
interpreted cautiously when CRP is elevated and that evaluating 25-OH-vitamin D in the 
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Chapter 1: Introduction 
Over recent years, several studies have been published which link 
hypovitaminosis D to increased risk for an array of acute and chronic inflammatory 
diseases, including cancer, diabetes, rheumatoid arthritis, cardiovascular disease, and 
mortality.
1-7
  In response to the conclusions of these studies, many experts have argued in 
favor of an increase in the threshold at which serum vitamin D levels are considered 
adequate.
1, 2, 8
  Additionally, many researchers have suggested that a large majority of the 
worldwide population is vitamin D insufficient and could benefit from vitamin D 
supplementation.
1, 2 
  Concerns surrounding this have grown and the term pandemic is 
now being utilized to describe the current hypovitaminosis D status of the world.
 1, 9
  
Prescriptions and sales of vitamin D supplements have escalated at a rapid rate
10
, yet a 
causal relationship between vitamin D status and disease still has not been demonstrated 
due to an absence of adequate randomized controlled trials investigating this association.
4
 
On the other hand, recent data have suggested that 25-hydroxyvitamin D (25-OH 
vitamin D), the circulating form of the vitamin, believed to be the most accurate indicator 
of an individual’s vitamin D status
1, 4
, is a negative acute phase reactant.
11
  This is 
momentous, as it reveals that 25-OH vitamin D is decreased in response to inflammation, 
ruling it an inaccurate indicator of vitamin D status in the setting of inflammation.  
Moreover, this suggests that low 25-OH vitamin D levels are the consequence of 
inflammatory diseases, rather than a cause for these diseases, potentially debunking the 
current widespread interpretation of the existing literature.
11
  It is imperative that 
researchers work to discern whether the trajectory being followed with widespread 
prescription of vitamin D is based on a fallacious interpretation of laboratory results.  
2 
 
Chapter 2: Research Question and Specific Aims 
 The primary aim of this study is to shed further light on the question of whether 
serum 25-OH vitamin D responds as a negative acute phase reactant.  The following aims 
and hypotheses were used to guide this study: 
1. Is 25-OH vitamin D significantly lower in patients with higher C-Reactive Protein 
(CRP) levels compared to those with lower CRP levels in a group of hospitalized 
patients with a variety of sources of acute and chronic inflammation? 
CRP is a laboratory marker of general inflammation.
12
  Other studies have looked at 
longitudinal data, in which the change of CRP and 25-OH vitamin D levels were assessed 
over time by comparing results before and after a particular inflammation-driving event, 
such as a surgical procedure or an acute myocardial infarction.  To the best of my 
knowledge, this will be the first study that examines this association across hospitalized 
patients with a variety of diagnoses. 
2. Does class of diagnosis function as an effect modifier in the examination of the 
association between CRP and vitamin D within this hospitalized population? 
Diagnosis impacts the source, degree, and duration of inflammation present.  Previous 
studies that have examined this relationship have found conflicting results, which could 
be due to different sources of inflammation studied in each one.  Therefore, it may be 
necessary to stratify the results based on this variable.   
The research hypothesis was that vitamin D levels would be significantly lower in 
patients with higher CRP levels compared to those with lower CRP levels and that the 
magnitude of this association would vary significantly based on class of diagnosis.   
3 
 
If the conclusion of this study were consistent with that hypothesized, this would 
indicate that 25-OH vitamin D is an inaccurate marker of vitamin D status when 
inflammation is present and would suggest that vitamin D supplementation might 
currently be prescribed in excess.  While vitamin D toxicity is rare, other potential 
unintended consequences of high-dose vitamin D supplementation are understudied, yet 
sales for these products have grown at an astronomical rate over recent years.
10
  Further, 
the Vitamin D Council is recommending that adults with infrequent exposure to the sun 
take 5,000 international units of vitamin D daily, which exceeds the tolerable upper limit 
set by the Institute of Medicine (IOM) of 1000 international units.
 10
 
Of note, Mursu et al. concluded that there may be increased total mortality risk 
associated with use of vitamin supplements in older women
13
, and in a sample of 15,167 
subjects from the National Health and Nutrition Examination Survey, Amer et al. 
concluded that 25-OH vitamin D at levels greater than 21ng/mL is associated with higher 
CRP levels.
14
  Both of these studies suggest the potential for some negative effects of 
micronutrient supplementation, as do studies that have demonstrated associations 
between high serum 25-OH vitamin D levels and increased all-cause mortality, cancers at 
some sites like the pancreas, and greater risk of cardiovascular events.
15
  Also 
noteworthy, the hospitalized population is one in which the addition of more pills to a 
medication regimen could contribute unnecessarily to discomfort, nausea, and cost.  
Finally, elevated levels of calcium and vitamin D, can contribute to calcification and 







Chapter 3: Background 
 
3.1 Existing knowledge 
3.1.1 Vitamin D 
 The primary role of vitamin D is to regulate concentrations of calcium, 
phosphorous, and magnesium in the bloodstream and contribute to bone growth.
1
  Over 
the past decade, vitamin D has recognized to function as a hormone and has been linked 
to a variety of additional body functions, such as immune system regulation and 
associated conditions, including autoimmune disorders, cardiovascular disease, and 
cancer.
1-7
  25-OH vitamin D is the major circulating form of vitamin D and circulates 
bound to a specific protein known as vitamin D binding protein (VDBP), which is found 
widespread throughout the body in a variety of different tissues.
15, 16
  Both endogenous 
and exogenous sources of vitamin D exist.  Endogenous vitamin D is produced when the 
skin is exposed to sunlight, whereas exogenous vitamin D is obtained from ingestion of 
foods and dietary supplements containing vitamin D.
 17, 18
 
The IOM has identified the acceptable level of 25-OH vitamin D to be 20ng/mL 
for bone health and reported that serum concentrations above 30ng/mL do not 
consistently provide additional health benefits.
15
  Many vitamin D experts argue that a 
higher cutoff should be utilized with some citing 50ng/mL as a more appropriate target 
for optimal health of other body systems.
8, 15
  However, the IOM cites concern associated 
with the frequent use of this figure, given the inconsistent representation in the literature 






Using the cutoff recommended by the IOM for diagnosing vitamin D deficiency 
of serum concentration </=20ng/mL, National Health and Nutrition Examination Survey 
(NHANES) data suggest that the prevalence of vitamin D deficiency in the United States 
is 41.5%.
2
  However, experts believing that a higher cutoff is more appropriate would 
argue that these figures should be much higher.
 1
  Risk factors for vitamin D deficiency 
include older age, darker skin tone (due to requirement for longer duration of sun 
exposure for synthesis vitamin D compared with fair skin counterparts), obesity (due to 
decreased bioavailability secondary to sequestration within adipose tissue), nutrient 
malabsorption, kidney dysfunction and other comorbidities, and lack of sunlight 
exposure, possibly due to season or hospitalization.
1, 8, 17, 18, 19, 20
  Some medications also 
influence vitamin D metabolism.
21 
3.1.2 C-Reactive Protein and Inflammation 
CRP is one key protein component of the  immune system made by the body in 
response to infection, trauma, or stress.
22
  CRP is recognized as an indicator of 
inflammation from an array of sources.
12
  The influence  inflammation has on a variety of 
nutrition markers has been recognized over recent years.
22
  For example, serum or plasma 
levels of iron, zinc, vitamin A, albumin and prealbumin decrease in the setting of 
inflammation and are therefore recognized as negative acute phase reactants.
19, 23, 24
  It is 
recommended that CRP levels be checked simultaneously, in order to interpret these 
results in the context of a given CRP level.
25
  When CRP is elevated, it is advised to rely 
on alternative methods for assessment of nutrition status, such as reported dietary intake, 
physical assessment, and weight changes.
26
  Current practice for clinical interpretation of 
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these lab values, based on the presence or absence of inflammation, is a very similar 
relationship to that being hypothesized for this study related to vitamin D. 
3.2 Analyses performed by others 
Waldron et al. conducted a longitudinal cohort study among 30 patients 
undergoing elective orthopedic surgery.
11
  Serum CRP, 25-OH vitamin D, and VDBP 
were measured before and 48 hours after knee or hip arthroplasty.
11
  Results of this study 
demonstrated a statistically significant increase in CRP and a statistically significant 
decrease in 25-OH vitamin D and VDBP when pre- and post-operative mean values were 
compared, thereby suggesting that both 25-OH vitamin D and VDBP decrease in 
response to the inflammation incurred by surgery.
11
  Similarly, Reid et al. conducted a 
cohort study of 33 patients undergoing elective knee anthroplasty and demonstrated that 
25-OH vitamin D levels significantly declined after surgery and remained significantly 
below baseline measurement at three months post-surgery.
3
  The results of this study 
support those of the previous study by demonstrating that vitamin D levels decrease in 
response to the inflammation incurred by surgery.
3
  Third, Louw et al. conducted a 
similar analysis in a prospective cohort study involving 26 patients undergoing 
orthopedic surgery and found that vitamin levels were decreased in response to the 
inflammatory response.
27
  As a result, they urged for the use of caution when interpreting 
serum vitamin levels during times of inflammation.
27
  Finally, in a cross-sectional study, 
Amer et al. demonstrated a significant  negative correlation between CRP and 25-OH 
vitamin D when 25-OH vitamin D was ≤ 21 ng/ml in a group of asymptomatic adults, 





 Contrastingly, Barth et al. conducted a cohort study among 32 patients following 
acute myocardial infarctions and concluded the opposite.
28
  In this study, it was 
determined that 25-OH vitamin D levels remained unchanged after this event and is 
likely an accurate marker of vitamin D status in patients surrounding a myocardial 
infarction.
28
  Likewise, Newens et al. concluded that 25-OH vitamin D levels do not 
change from vitamin D levels during malarial infection after recovery from malarial 
infection in 14 subjects followed for two to six weeks after malarial infection.
29
 
 Of the few randomized controlled trials that have been conducted, results have 
been contradictory with some revealing a decrease in inflammatory biomarkers and 
others concluding no effect, upon supplementation with vitamin D.
7, 30 31, 32   
Schleithoff et 
al. conducted a double-blind, randomized, placebo-controlled trial in which patients with 
congestive heart failure (n = 93 completed the study) were randomized to receive either a 
vitamin D and calcium supplement or a placebo for 90 days.
 30
  Results indicated a 
statistically significant decrease in parathyroid hormone and anti-inflammatory cytokine 
interleukin 10 after 9 months of supplementation, compared with baseline levels, while 
there was no significant difference in survival rate between the two groups.
30  
Van Den 
Berghe et al. randomized 22 critically ill patients in an intensive care unit to receive 
either 200 international units or 500 international units vitamin D supplementation.  
Results indicated that CRP decreased over time and that this decrease was more 
pronounced in the higher dose supplementation group.
31
  Witham et al. conducted a 
randomized, parallel group, double-blind, placebo-controlled trial in a group of 105 
patients with systolic heart failure, in which patients were randomized to receive either 





Multiple measurements were utilized to assess physical function and quality of life at 
various timepoints and there was no improvement observed upon any measure for those 
in the treatment group.
32
   
3.3 Knowledge gaps 
 The conflicting results of these studies demonstrate a lack of consensus related to 
the influence of inflammation on the accuracy of 25-OH vitamin D measurements.  
Secondly, these differing findings indicate that there may be differences in this 
association dependent on the source of the inflammation.  To my knowledge, there have 
been no studies to date that investigate this relationship in patients with chronic disease-
driven inflammation.
3
  For these reasons, it is imperative that studies are conducted to 
assess this association in a broader range of patients and to specifically investigate the 
possibility of effect modification on the basis of class of diagnosis, a gap that is evident 
in the existing literature. 
3.4 Importance of the study 
If 25-OH vitamin D were a negative acute phase reactant, this would hold 
substantial significance to human health.  This would indicate that cases of vitamin D 
deficiency are currently being over-diagnosed worldwide and prescription of vitamin D 
supplementation is being done in excess.  This also may explain one remaining mystery 
related to vitamin D, which is that while 25-OH vitamin D levels increase in response to 
increased intake of vitamin D, the relationship is nonlinear.
17
  Perhaps the reason is that 
the degree of inflammation present for each individual mediates this relationship.   
The results of this study also pinpoint a new factor that should be considered in 
past and future vitamin D studies by including CRP as a confounding factor in their 
9 
 
analysis.  For example, a study that was recently published in May 2014 by Hansson et 
al. concluded that vitamin D levels affect outcomes in pediatric hematopoietic stem cell 
transplantation.
5
  However, it is possible that the true factor responsible for the difference 
in outcomes between those with high versus low levels of vitamin D could be that 
vitamin D levels actually served as a surrogate indicator of inflammation status for those 
having lower levels of inflammation associated with their disease.  If inflammation, 
measured as CRP, had been included in the multivariate analysis model, it would be 
interested to see if the same results were reached.  
The 2010 Dietary Guidelines for Americans state that the nutrients should 
preferentially come from foods.
33
  Therefore, some health professionals have questioned 
the accuracy of the notion that supplemental vitamin D in pill form is necessary to 
prevent vitamin D deficiency.  There are limited natural dietary sources of vitamin D and 
exposure to sunlight is generally inadequate to allow for synthesis of vitamin D in the 
quantities researchers are now suggesting are adequate for optimal health.
2, 8
  It is 
important to keep in mind that supplementation of nutrients in pill form is not always 
beneficial and can even elicit undesired side effects or outcomes.  Therefore, it will be 
important to discern whether the trajectory being taken is based on a fallacious 




Chapter 4: Research Design and Methods 
 
4.1 Study design  
 A retrospective study design was conducted utilizing electronic health record data 
from a clinical research data repository, the National Institutes of Health (NIH) Clinical 
Center Biomedical Translational Research Information System (BTRIS).  BTRIS is a 
data repository available to NIH intramural researchers, which was developed to 
consolidate clinical research data into one single database.
34
  One intended use of this 
database is for the reuse of clinical research data captured in the electronic health record 
to answer new research questions.
34
  The database currently captures more than half a 
million subjects (~515,000) and over 9 billion rows of data.
35
  Each row of data yields a 
variety of data types for a given subject, ranging from a given vital sign or medication 
administered to a laboratory test result or medical problem.
34
  Subjects include an 
international population with a variety of diseases and conditions, including some with 
very rare diagnoses and normal volunteers.  For the purposes of this study, data were 
pulled from a variety of completed and active clinical research protocols that have been 
conducted across several NIH institutes.  
4.2 Subjects and data pairing 
There were 1,043 subjects included in this analysis.  Figure 1 outlines the steps 
taken throughout the data acquisition and cleaning process.  First, a limited dataset query 
was conducted to capture deidentified data on all subjects admitted to the NIH Clinical 
Center since the year 1976 that have had CRP and 25-OH vitamin D levels measured (n = 
2,100).  Second, all subjects under the age of 18 years were deleted (485 subjects 
eliminated), leaving a total of 1,615 subjects in the sample.  Third, vitamin D levels were 
11 
 
paired with the highest CRP value measured over the previous 3 months for each subject.  
This 3 month cutoff value was selected based on a previous study that demonstrated a 
lasting impact of inflammation, or CRP, on vitamin D levels for 3 months after the 
elevated level.
3
  Subjects without a CRP level checked within 3 months of a vitamin D 
level were eliminated (316 subjects were eliminated), bringing the sample size to 1,299 
subjects.  For any subjects with multiple possible data pairs, the first pair only was 
selected, in order to ensure that all data pairs remain independent of one another for 
compliance with assumptions of statistical tests.  This decision was made based on the 
idea that earlier pairs would be closer to baseline and may be less likely to be influenced 
by any treatments or other factors occurring through study participation at the NIH 
Clinical Center.   
Next, all subjects taking vitamin D supplementation that exceeded 400 
international units at the time the lab was checked were excluded (266 eliminated), 
leaving a total of 1,033 subjects in the sample.  The cut off of 400 international units was 
selected based on the fact that this is the amount of vitamin D contained in most general 
multivitamins, including those prescribed at NIH.  Multivitamin use or use of a vitamin 
supplement containing 400 international units or less of vitamin D was assessed as a 
potential confounder in the analysis.  
High-sensitivity CRP data was obtained from one Principal Investigator, Dr. Jack 
Yanovski.  Approximately 25% of the sample was composed of patients that had been 
admitted under one of his protocols.  In order to increase the proportion of CRP values 
that were generated from high-sensitivity CRP testing, these were substituted for the 
original subjects from his protocol that had initially been gathered through BTRIS with 
12 
 
regular CRP values.  In order to ensure there was no duplication of these subjects, all 
subjects from the original dataset enrolled on Dr. Yanovski’s protocol were eliminated.  
The high-sensitivity CRP data provided by Dr. Yanovski was then added.  A greater 
number of subjects was available in the newly added sample than were initially removed 
from the dataset, hence the sample size of the CRP-HS subset increased following this 
step.  Finally, 49 subjects were eliminated due to missing BMI data.  This brought the 
total final analytic sample size to 1,043 subjects. 
4.3 Description of variables 
4.3.1 Dependent variable 
The dependent variable of interest was serum vitamin D levels, measured as total 
25-OH vitamin D.  This variable was treated as a continuous variable.  Of the different 
forms of vitamin D that can be measured in the blood, this form has been identified 
among vitamin D experts and clinicians as the most reliable marker of vitamin D status.
1,6
 
4.3.2 Independent variable 
The independent variable of interest was inflammation, measured as CRP, and 
also treated as a continuous variable.  CRP is described as a non-specific test, meaning 
that it is an indicator of inflammation without identifying any specific source or type of 
inflammation.
12
  Infections, inflammatory diseases such as lupus or inflammatory bowel 
disease, cancer, and post-operative status are examples of potential sources of such 
inflammation.
12
  Obesity has also been cited as a condition in which CRP may be 
elevated.
2, 20
 CRP levels can also be used to assess risk for heart disease.
12
  To give an 
idea of significance of CRP levels, results are generally interpreted as follows:
12
 
 <1.0mg/L  Low risk of heart disease 
13 
 
 1.0 – 3.0mg/L  Average risk of heart disease 
 3.0 – 8.0mg/L  High risk for heart disease 
 >8mg/L  Serious inflammation or infection 
Contrary to some other markers of inflammation, CRP responds quickly to changes in 
levels of inflammation and therefore is an accurate marker of acute changes in 
inflammation.
12
  Both high-sensitivity and conventional CRP data were included in this 
dataset.  The high-sensitivity CRP test, which was recently developed, is able to detect 
lower levels of inflammation and is therefore more useful than standard CRP values for 
assessing risk of cardiovascular disease and associated complications.
36
  Both measures 
are still recognized as acceptable markers of inflammation.
35 
 
4.3.3 Potential confounders 
Several additional variables were examined as potential confounders.  Age and 
BMI were analyzed as continuous variables.  Race/ethnicity were analyzed as a 
categorical variable with categories designated as White, non-Hispanic; Black, non-
Hispanic; Hispanic or Latino; or other.  Sex was analyzed as a binary variable with all 
subjects categorized as male or female.  Comorbidities and medications known to 
potentially influence vitamin D levels were both considered as possible confounders.  
They were categorized as binary variables, as presence or absence of a comorbidity of 
interest and taking or not taking a medication of interest.  Comorbidities accounted for in 
this assessment included kidney dysfunction, malabsorbtive syndrome, and end-stage 
liver disease.
12, 19
  Medications accounted for in this assessment included estrogen, 
Isoniazid, Thiazide, Antacids, Anti-seizure medications, bile acid sequestrants, Rifampin, 
mineral oil, Orlistat or Alli, and steroids.
21, 37
    Season was analyzed as a categorical 
14 
 
variable based on date upon which 25-OH vitamin D levels were measured and was 
classified as Winter (December through February), Spring (March through May), 
Summer (June through August), or Fall (September through November).  These cutoffs 
were selected in order to be consistent with other analyses that have been conducted in 
the literature.  Finally, class of diagnosis was categorized into groups with other similar 
diagnoses.  Ten categories were utilized, including lipodystrophy, auto-immune diseases, 
normal volunteers, Turner syndrome, immune defect disorders, ovarian dysfunction, 
alcohol dependence, lipid processing and storage disorders, chronic graft versus host 
disease, disturbances of amino-acid transport, and other diseases.  For more information 
about the specific diagnoses included under each of these categories, please refer to 
Appendix A.  These variables were each selected based on evidence in the literature that 
they influence vitamin D levels or metabolism. 
4.4 Statistical analysis 
Secondary data analysis was conducted in this study.  A descriptive analysis was 
performed first, in order to assess the distribution of each of the variables of interest 
across the study sample and to identify missing values. Sharpiro-Wilk tests were used to 
check whether the normality assumption was violated for any continuous variable and to 
determine whether non-parametric tests were needed.   Next, bivariate analysis was 
implemented to evaluate the unadjusted relationship between each covariate and the 
dependent variable, 25-OH vitamin D.  Non-parametric tests were used to compare the 
medians of the continuous outcome variable (25-OH vitamin D) between groups of 
categorical variables.  Wilcoxon-Mann-Whitney test was used for two-group comparison 
and Kruskal-Wallis test was used for multiple-group comparison.  Two-sided tests were 
15 
 
applied, given that there is no reason to assume a single direction of interest.  Since all 
continuous variables violated the normal assumption, Spearman’s rank correlation 
coefficients were calculated to assess the association between CRP and 25-OH vitamin D 
levels, as well as to examine the unadjusted relationship between each continuous 
covariate and the dependent variable, 25-OH vitamin D.    
From there, multiple linear regression was utilized to further assess the 
relationship between CRP and 25-OH vitamin D.  Potential confounding effects 
(including age, sex, BMI, season, race/ethnicity, and medications and comorbidities 
known to potentially influence vitamin D levels) were assessed in the model.  Decisions 
about which variables to include in the final model were made based on the statistical 
analysis, as well as based on the literature.  Any variables deemed to be confounders 
evidenced by producing a change in the regression coefficient estimate for the association 
between CRP and 25-OH vitamin D of greater than 10%, were included in the final linear 
regression model.  Variables identified for inclusion in the model based on a 10% change 
included race/ethnicity and multivitamin supplementation.  BMI was also included in the 
final model based on evidence in the literature that BMI has an association with both 
CRP and vitamin D.
 1, 2, 18, 19, 20, 21, 38 
  Individuals with higher BMI are known to have 
higher CRP levels and lower 25-OH vitamin D levels.
1, 2, 18, 19, 20, 21, 38 
  One noteworthy 
point is that the mechanism for the association between obesity and vitamin D exceeds 
that which could be attributed to the inflammation associated with obesity.  Based on 







The final model was selected as follows: 
E(Vitamin D) = Intercept + β1CRP + β2Other races + β3Hispanic or Latino + 
β4Black  + β3MVI + β4BMI 
Class of diagnosis was temporarily added to the model, along with the associated 
interaction term, in order to test for significance as an effect modifier.  However, it was 
determined not to contribute significantly to the model based on the p-value associated 
with the interaction term, and thus was removed. 
Variance inflation factors (VIFs) were calculated to test for collinearity, and the 
standard threshold value of 10 was used when conducting such tests.  No evidence of 
multicollinearity was observed (VIF ≤ 4.59 for all variable categories). Confidence 
intervals were reported, and a type I error rate α of 0.05 was utilized to determine which 
results were statistically significant.  Statistical analysis was conducted using SAS 
version 9.3 software.   
4.5 Human subjects and IRB 
A human subjects research determination form was submitted to the University of 
Maryland Institutional Review Board (IRB) and was determined to be exempt for full 
board review.  This process has also been confirmed through the NIH IRB, as well.  
Official certificates are available from both institutions and are included in Appendices B 




Chapter 5: Results 
5.1 Descriptive statistics 
The study analytic sample included 1,043 patients with a majority being female 
(71%) and white (72%).  The mean age of the patients was 39 years (ranging from 18 to 
79 years), and the mean BMI was 28 kg/m2 (ranging from an underweight status of 13.0 
kg/m2 to an obesity class III status of 58.2 kg/m2).  The sample was approximately 
evenly distributed among the four seasons and between type of CRP measured (56% with 
non-high-sensitivity CRP vs. 44% with high-sensitivity CRP).  The majority of patients 
did not have any of the comorbidities of interest and were not taking any of the 
medications of interest, including multivitamin or other vitamin supplement containing at 
most 400 international units of vitamin D.  Diagnoses were classified into 10 different 
disease types, with the majority of patients classified as normal volunteers (28%) or as 
having ovarian dysfunction (16%).  For the independent variable, the mean CRP value 
was 0.87 mg/dL (ranging from a normal value of 0.01 to a value indicating severe 
inflammation of 33.6 mg/dL).  For the dependent variable, the mean 25-OH vitamin D 
level was 24.67 ng/mL (ranging from a severely deficient value of 1 to an optimal value 
of 88 ng/mL).  Table 1 illustrates details of the descriptive statistics.  
5.2 Bivariate analysis 
 
 The bivariate analysis revealed significant differences in median 25-OH vitamin 
D levels between categories for multivitamin (p = 0.0008), race (p <0.0001), season (p = 
0.03) and class of diagnosis (p = 0.002), and significant correlation between 25-OH 
vitamin D with CRP (p <0.0001), age (p = 0.04), and BMI (p <0.0001).  A marginally 
significant association was observed for 25-OH vitamin D with comorbidities (p = 0.09).  
18 
 
There were not significant differences observed for the other variables, including sex and 
medications.  These results show the existence of significant relationships between the 
dependent variable and independent variable, as well as between the dependent variable 
and some of the confounding factors. 
 5.3 Model selection  
As described in the methods section, the final model was identified based on 10% 
change in estimate method and based on the literature.  After substituting in the β
estimates from the analytical output, the equation reads as follows:   
E(Vitamin D) = 28.63 + (-0.39)*CRP + (7.16)*White + (1.89)*Hispanic or Latino 
+ (-1.63)*Black + (-2.59)*MVI + (-0.23)*BMI 
5.4 Results 
The β estimate for the association between CRP and vitamin D was attenuated 
after multi-variable adjusted analysis but a statistically significant, negative association 
remained.  Based on the change in estimate analysis, race was identified as the variable 
with the greatest degree of confounding effects (yielded a 21% change in estimate).  
Multivitamin supplementation was determined to be the second greatest contributor of 
confounding effects (yielded a 14% change in estimate).   
Additional noteworthy results are evident based on the data displayed in Table 2.  
Among race groups, after adjusting for CRP, BMI and multivitamin, Blacks have a 
decrease of 25-OH vitamin D of -8.79 ng/mL (p <0.0001), Hispanic or Latino have a 
decrease of 25-OH vitamin D of 5.27 ng/mL (p = 0.0002), and  other races have a 
decrease of -7.16 ng/mL (p <0.0001), compared with Whites.  Also those taking a 
multivitamin or low-dose vitamin D supplement would have an increase of 25-OH 
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vitamin D of 2.59 ng/mL (p = 0.01) compared with those that are taking a supplement 
after adjusting for other factors.  Finally, for each one unit increase in BMI, 25-OH 
vitamin D would be expected to decrease by 0.23 ng/mL (p <0.0001) after adjusting for 
other factors. 
Lastly, the hypothesis that class of diagnosis serves as an effect modifier of this 




Chapter 6: Discussion 
6.1 Conclusions 
A greater understanding of the relationship between inflammation and vitamin D 
is vital to help clinicians accurately interpret laboratory results of patients.  As was 
discussed throughout the introduction, there has been considerable discrepancy among 
studies previously conducted to examine the association between inflammation and 
vitamin D.  It is suspected that this is due to small sample size, limited representation of 
different degrees and sources of inflammation, and inability to account for key 
confounding variables, such as race and vitamin supplementation.  This study improves 
upon many of these prior limitations and fills many remaining research gaps, as it 
analyzes data from a large sample of subjects with a wide variety of health conditions.  It 
also is one of the first studies to investigate the association between CRP and 25-OH 
vitamin D in lower levels of inflammation and was able to account for both acute and 
chronic sources of inflammation.  Finally, this study also included assessment for a wider 
range of confounding factors.   
The findings of this study support that there is an association between CRP and 
25-OH vitamin D, and that a change in clinical and research practice may be needed.  
These results, in conjunction with the conclusions of supporting studies cited, suggest 
that the accuracy of 25-OH vitamin D levels declines when inflammation is present.  
From a clinical application standpoint, this is a highly important finding, as it provides 
evidence to support a need to concurrently check a CRP level when checking a 25-OH 
vitamin D level.  When CRP is elevated, 25-OH vitamin D levels should be interpreted 
cautiously and checking levels when CRP is lower would be beneficial.  Lastly, use of 
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alternative tools for assessment of vitamin D status is recommended, especially when 
inflammation is present.  Examples of such factors may include diet recall, assessment of 
risk for malabsorption, questions about lifestyle and sunshine exposure, and DEXA scans 
to assess bone mineral density. 
Specifically, the results of this study demonstrate that for every 1 mg/dL increase 
in CRP, 25-OH vitamin D decreases by 0.39 ng/mL.  Clinically, this would suggest that 
the association between CRP and 25-OH vitamin D is most important at higher levels of 
inflammation.  For example, a patient with a CRP of 1 mg/dL would not be expected to 
have a clinically relevant change in 25-OH vitamin D.  However, a patient with a CRP of 
20 mg/dL may have a reduction in 25-OH vitamin D of 8 ng/mL, which could certainly 
alter the results of the test and decisions surrounding vitamin D supplementation.  
Further, it should be recognized that the data pairing approach used in this study would 
be expected to result in a conservative estimate of this association, since the association 
would be strongest when levels are measured closest to one another.  In other words, 
Reid et al. found that the greatest changes occurred at the point of the systemic 
inflammatory response and then diminished but remained statistically significant at the 3 
month post-operative mark.
3
  Therefore, one could expect that if our data pairs all 
reflected the peak CRP level paired with a 25-OH vitamin D level measured close to that 
value, an even stronger association may have been observed, which may demonstrate 
greater clinical significance at a wider variety of CRP levels.   
From a research perspective, one key recommendation is that investigators should 
assess CRP, or other markers of inflammation, as potential confounding factors in all 
future studies examining 25-OH vitamin D as a predictor of other diseases and outcomes.  
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The findings of this study combined with the existing literature support the conclusion 
that inflammation could be confounding the results of such studies.  One example of a 
study that could have benefited from assessing inflammation as a confounding factor was 
described in the introduction.  Hansson et al. concluded in a paper published in May 2014 
that vitamin D levels affect outcomes in pediatric hematopoietic stem cell 
transplantation.
5
  However, it is possible that the true factor responsible for the difference 
in outcomes between those with high versus low levels of vitamin D could be that those 
with seemingly higher vitamin D levels actually served as a surrogate indicator for those 
having lower levels of inflammation associated with their disease.  It would be interesting 
to see if the same results held true if inflammation had been included in the multivariate 
analysis model. 
The statistically significant findings related to race and multivitamin use as 
confounding factors described in the results section are consistent with existing literature.  
Given what is known about skin pigmentation and ability to synthesize the active form of 
vitamin D from sunlight, it was expected that whites would have higher levels of vitamin 
D and Blacks would have lower levels of vitamin D, independent of other factors.
 1, 8, 17, 
18, 19, 20
  A majority of this study population was White, which explains why adjustment 
for race had such a significant contribution to the attenuation in the β estimate for CRP.  
The unadjusted estimate was confounded by the fact that Whites generally have lower 
inflammation levels and higher 25-OH vitamin D levels compared with other races, 




  One would also expect that 
supplementation of vitamin D, even at low levels, would result in an increase in vitamin 
D level after controlling for other variables.  A smaller proportion of the sample was 
23 
 
taking a multivitamin, explaining why a smaller contribution to the attenuation occurred 
for this variable, compared with race.  Nonetheless, vitamin supplementation is 
associated with a decrease in inflammation and an increase in 25-OH vitamin D, thereby 
falsely elevating the β estimate for CRP in the unadjusted analysis.
40 
 Finally, several 
prior studies have demonstrated that 25-OH vitamin D levels are lower and CRP is higher 
in individuals with higher BMI, which again would falsely magnify the unadjusted 
association.
 20, 38 
As for the lack of effect modification by class of diagnosis, it could be that this is 
due to a couple of different factors.  First, there may be some inflammation driving 
events unaccounted for, such as scheduled procedures or fevers, which would not be 
reflected in the class of diagnosis variable but which would also alter the source and 
degree of inflammation.  For example, if a patient had a class of diagnosis generally 
associated with low amounts of inflammation but that person had recently undergone a 
procedure that caused an acute sudden increase in inflammation, this would be 
unaccounted for in the class of diagnosis variable.  Second, a lack of adequate sample 
size within each class of diagnosis could have limited the power to detect significance.  
Or a third possibility is that it is not actually the source of the inflammation that modifies 
the association between CRP and 25-OH vitamin D after all.  This is supported by the 
results of this study, which indicate that across a wide variety of diagnoses, in patients 
with both high and low levels of inflammation, and in the setting of both chronic and 





6.2 Comparison with existing studies 
A majority of studies that have demonstrated a significant decline in 25-OH 
vitamin D in response to inflammation have been studied in small samples of patients 
with limited representation of a variety of conditions, given that most of these studies 
looked at patients specifically undergoing orthopedic surgery.  This lends to the question 
of whether or not there is something specifically related to this type of surgery that is 
causing the reduced 25-OH vitamin D levels observed in these cases, rather than the 
inflammation itself as was concluded by the authors.  In other words, it is unclear 
whether these results could be generalized to a wider variety of patients, given the limited 
study population.  However, the fact that the present study sample contained a wide 
variety of diagnoses for which orthopedic surgeries was not indicated and still found 
positive results, rules out this as the sole contributor to the findings in these studies, 
thereby supporting the findings that 25-OH vitamin D is in fact a negative acute phase 
reactant. 
 As noted previously, the a priori hypothesis was that class of diagnosis would 
modify this association.  This hypothesis was made based on the idea that the type and 
degree of inflammation, such as that generated by a surgical procedure versus that 
generated by a chronic illness for instance, may contribute differences to the association 
between CRP and 25-hydroxyvitamin D.  It is important to note that this present study 
included a wide variety of types and sources of inflammation.  The fact that a positive 
and significant association was observed in a sample with such a varied set of health 
conditions and status supports that this association may be applicable to many other 
populations.   
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This also brings up the point of degree of inflammation present in the study 
subjects.  In the present study, the mean CRP value was 0.87 mg/dL, which is 
significantly lower than the post-operative mean CRP values of the studies that 
demonstrated statistically significant, positive findings (Waldron et al. mean post-
operative CRP: 8.12 mg/dL; Reid et al. median day 3 post-operative CRP: 18.9 mg/dL).  
Unfortunately, CRP values were not reported for either of the two studies described with 
null findings.  Regardless, there is now evidence demonstrating a significant association 
between CRP and 25-OH vitamin D in a population that contains both high and low 
levels of inflammation. 
Similarly, one can also speculate about the influence of the duration of the 
inflammation on vitamin D levels.  Many of the prior studies with positive findings were 
investigating the association between CRP and 25-OH vitamin D in the setting of an 
acute inflammatory response related to surgery, whereas many of the subjects in the 
present study had chronic diseases or long-standing illnesses that are associated with 
chronic inflammation at varying levels.  Again, there is now evidence demonstrating a 
significant association between CRP and 25-OH vitamin D in a population with both 
acute and chronic drivers of inflammation.   
Upon closer review of the studies presented previously which reported null 
findings in contrast to the results of this present study, some notable limitations were 
evident.  First, in the study conducted by Newens et al., which looked at changes in 25-
OH vitamin D levels during malarial infection, the small sample size is a limitation.  
There were only 25 subjects included in the analysis and some of these were lost to 
follow-up.  Furthermore, attrition occurred disproportionately between groups in that 
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subjects with higher baseline 25-OH vitamin D levels were less likely to return for 
follow-up, and this may have introduced bias.  Additionally, the baseline levels were 
checked upon admission, which occurred after the infection and associated symptoms 
were already present, which may mean that even the baseline levels were affected by 
inflammation. So, when 25-OH D levels were compared to baseline, the difference would 
have been muted or less than actual.  Finally, the authors did not collect information on 
race, which was found to be the most prominent confounding factor in this study and 
thereby may have significantly confounded their results. 
Second, in the study by Barth et al. looking at 25-OH vitamin D levels before and 
after acute myocardial infarction, limitations were also noted.  Again the sample size was 
small (n = 32).  Also the labs were again checked after initial presentation with 
symptoms, suggesting that the 25-OH vitamin D levels may have already been affected 
by the existing inflammation, thereby reducing the difference.  Additionally, no data were 
collected related to vitamin D supplementation, which was another major confounding 
factor identified in the present study, even after exclusion of any subjects taking >400 
international units of vitamin D per day.  The fact that even low levels of vitamin D 
supplementation significantly confounded the unadjusted association in the present study 
suggests that this could be a very significant limitation of this study by Barth et al. 
There are multiple other noteworthy differences between the present study and 
prior studies.  One such difference is the decision to pair 25-OH vitamin D levels with the 
highest CRP value recorded within 3 months prior.  This decision was made based on the 
study by Reid et al. which found that 25-OH vitamin D levels remained significantly 
below baseline levels up to 3 months after surgery and the associated rise in CRP. 
3
  Of 
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note, this does exceed the half-life of vitamin D (15 days)
17
, but it is possible that the 
mechanisms by which 25-OH vitamin D levels drop create a lasting effect on vitamin D 
metabolism.  For example, a possible explanation could be if vitamin D binding proteins 
or receptors were affected.   
From the standpoint of considerations for future studies, another noteworthy 
factor is that only CRP was analyzed as a marker of inflammation.  This is recognized as 
a non-specific marker that increases in response to a variety of sources of inflammation, 
making it the ideal biomarker for inflammation.  However, there are still some diseases or 
drivers of inflammation that are not necessarily reflected in CRP values.  For example, 
per communication with Dr. Alexandra Freeman, a physician working at the NIH Clinical 
Center for the National Institutes of Allergy and Infectious Disease, some patients in this 
study have underlying immune defects that may result in inflammation that is not 
reflected in CRP values.  There are multiple other measures of inflammation, such as β-2-
microglobulin and erythrocyte sedimentation rate that could be considered in future 
studies.   
6.3 Strengths and limitations 
Several strengths and limitations are evident in this study. Beginning with the 
strengths, one key component is that the data are pulled directly from an electronic 
medical record, thereby avoiding any potential recall bias that can be introduced based on 
retrospective self-reported data.  Another strength is the large analytic sample size (n = 
1,043) and wide age range (ages 18 – 79 years), which helps to increase the power and 
validity of the results.  Third, this study design allows for a quick and inexpensive means 
by which to examine this association in a population that has not already been tested.  
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Fourth, capturing 25-OH vitamin D values that occur at the time CRP is measured or up 
to three months after demonstrates temporality, as each vitamin D reflects the period in 
which inflammation, or lack thereof, would be expected to influence the results.  Further, 
use of this particular dataset allows for a unique capture of a large group of individuals 
with a variety of diagnoses, which allowed for assessment of the theory of whether 
discrepancy observed in previous studies may be related to the source of inflammation, a 
gap that is evident in the existing literature.  And finally, there is a fairly wide range of 
characteristics and lab values captured in this sample, including age range, CRP range, 
25-OH vitamin D levels, and BMI. 
There are also some limitations that come along with the reuse of electronic 
health record data, such as the potential introduction of bias based on the inclusion and 
exclusion criteria for each individual protocol on which the patients were enrolled.  Every 
patient admitted at the NIH Clinical Center must be enrolled on a given study protocol.  
Each of the many study protocols on which the patients included in this study population 
were initially enrolled had different inclusion and exclusion criteria, which may have 
influenced the characteristics of the sample.  This makes this population unique relative 
to other hospitalized populations in ways that are difficult to predict.   
Similarly, there may be some additional unknown potential confounders, such as 
unknown comorbidities, medications, procedures, or other factors that could influence 
CRP and/or vitamin D levels.  Also, the inability to dictate the time points at which both 
of the labs of interest were ordered is a limitation, as this results in pairing of values that 
were measured at varying amounts of time from one another, up to three months 
difference.  Additionally, this may restrict representation of this relationship during 
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situations in which CRP is very high within this dataset.  In other words, while CRP 
levels >100mg/L are often observed in the patient population being studied, it is not as 
common for 25-OH vitamin D levels to be tested alongside the tracking of CRP.  
Therefore, there is a small number of patients captured in this dataset with very high CRP 
levels relative to that observed in the patient population at the NIH Clinical Center, due to 
a lack of corresponding 25-OH vitamin D levels for those values.  Regardless, being able 
to explain this association at lower levels of CRP is a significant and meaningful 
contribution to the literature.  Additionally, this helped to fill another gap in the existing 
literature, as most studies described in this paper were conducted in patients with acute, 
high level inflammation, such as that driven by surgery.  The values represented in this 
study are more representative of a greater proportion of people.  For instance, secondary 
to obesity or other underlying chronic conditions, many people function daily with a 
chronic low level of inflammation.  Of note, given that this study is conducted in 
hospitalized patients, the results may not be generalizable to the greater population, 
although the fact that 25% of the sample is composed of normal volunteers may suggest 
some generalizability.   
Final potential limitations can be identified as the fact that sun exposure using 
home location was not controlled for, despite recognition of proximity to the equator as 
having a potential impact on 25-OH vitamin D levels.  This decision was made based on 
the fact that some patients had been in the Clinical Center in Bethesda, MD for several 
months, thereby making their home address an inaccurate marker of proximity to the 
equator.  Plus, Mansoor et al. demonstrated that the shielding of skin from the sun makes 
vitamin D deficiency common even in highly sunny locations, such as Pakistan.
1
   
30 
 
Lastly, data related to dietary intake of vitamin D are not available for this study 
sample.  Given that we found that taking a multivitamin or very low level vitamin D 
supplement (no more than 400 international units of vitamin D) had a statistically 
significant influence on the results, this may be contributing confounding effects in this 
analysis.  Further, a study sample with a majority of inpatient, hospitalized patients would 
be expected to potentially have a high degree of variability of vitamin D intake, as some 
may have abnormally high or low appetites for a variety of reasons.  That said, no other 
studies have been able to account for this variable either.  Finally, vitamin D 
supplementation could only be accounted for in those patients taking the supplement 
during the admission when the CRP and 25-OH vitamin D measurements were taken.  
There may have been some instances in which patients were taking vitamin D 
supplementation and stopped upon admission that were missed. Therefore, it is possible 
that some of the vitamin D levels in the study were inflated by previous vitamin D 





Chapter 7: Public Health Significance 
 Current widespread belief among researchers and clinicians alike is that vitamin 
D deficiency is a cause of a growing number of inflammatory diseases.  However, some 
newer evidence suggests that vitamin D may actually respond as a negative acute phase 
reactant, thereby decreasing in the setting of acute inflammation independent of true 
changes in vitamin D status.   This could indicate that 25-OH vitamin D levels are not an 
accurate measure of vitamin D status in the setting of inflammation, a hypothesis that the 
results of this study strongly support. 
This gain of information related to the relationship between CRP and vitamin D is 
highly relevant to clinical practice.  Recognizing that this negative acute phase response 
does occur in this population with a variety of sources of inflammation, such as that 
driven by cancer, infection, or general chronic lower levels of inflammation, is 
imperative in order to ensure that clinicians are accurately identifying vitamin D deficient 
patients.  At this point, it appears that more frequent checking of 25-OH vitamin D levels 
and trending with CRP levels is necessary to accurately diagnose a vitamin D deficiency.   
Also, considering additional assessment factors to determine deficiency risk is highly 
important, particularly in the setting of inflammation. 
Given that discrepancy remains within the literature and that this study 
demonstrated a significant association between CRP and vitamin D, further studies of this 
relationship will be highly beneficial.  For future studies, it would be recommended to 
impart alternative data pairing methods, such as utilizing the closest chronological CRP 
value to each 25-OH vitamin D level.  More longitudinal studies with larger and more 
varied study populations would be ideal for demonstrating temporality, as well.  
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Incorporating additional inflammatory markers into the analysis could be useful.  And 
finally, it is recommended that all future studies investigating disease outcomes 





Chapter 8: MPH Competencies Addressed in Thesis 
 In completing this study, several MPH competencies were addressed.  Key 
sources of epidemiological data and vital statistics have been utilized during the literature 
review.  Vitamin D deficiency has been described in terms of magnitude, person, time 
and place when citing prevalence statistics and other associated parameters.  In justifying 
the public health significance and long term relevance of this study, the importance of 
epidemiology for informing scientific, ethical, economic, and political discussion of 
health issues has been explained.  Epidemiological terminology and definitions were 
utilized throughout the verbal and written reporting of this study, as well as epidemiology 
measures.  Written and oral presentation of the proposal and findings of this study to 
various groups will achieve the communication of epidemiologic information to lay and 
professional audiences.  When commenting on strengths and limitations of this study, as 
well as other studies reviewed as references, Hill’s causal criteria, strengths and 
limitations of different epidemiology study designs, and strengths and limitations of 
epidemiologic reports were all addressed.  Advanced epidemiologic measures were 
calculated during the data analysis and results reporting phases.  The entire process of 
completing this thesis pertains to designing, analyzing, and evaluating an epidemiological 
study.  Finally, ability to collect and manage public health data was demonstrated through 















Figure 1. Data Acquisition and Cleaning 
 
  
BTRIS query: All 
subjects that have had 
25-OH vitamin D and 
CRP levels measured  
(n = 2100) 
Eliminated 485 
subjects <18 years old  
(n = 1615) 
Vitamin D levels 
paired with highest 
CRP recorded over 
previous 3 months 
Eliminated 316 
subjects without a 
CRP checked within 3 
months of vitamin D 
(n = 1299) 
Subsequent data pairs 
were deleted for 
subjects with multiple 
possible pairs 
Eliminated 266 
subjects taking >400 
international units 
vitamin D  
(n = 1033) 
Substituted hsCRP 
data from Dr. 
Yanovski for SCOOP 
study subjects  
(n = 1092) 
Eliminated 49 
subjects with missing 
BMI data  
(n = 1043) 
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Table 1. Descriptive Characteristics (n = 1,043) 
Categorical Variables 
Characteristic Category Number Percent 
Sex Female 739 70.85 
 Male 304 29.15 
Race White 750 71.91 
 Black 179 17.16 
 Hispanic or Latino 65 6.23 
 Other 49 4.70 
Season Spring 289 27.71 
 Winter 261 25.02 
 Fall 248 23.78 
 Summer 245 23.49 
Medications No 818 78.43 
 Yes 225 21.57 
Multivitamin intake No 858 82.26 
 Yes 185 17.74 
Class of diagnosis Normal volunteer 293 28.09 
 Ovarian dysfunction 165 15.82 
 Other 128 12.27 
 Turner syndrome 117 11.22 
 Auto-immune disease 76 7.29 
 Alcohol dependence 65 6.23 
 Disturbances of amino acid transport 52 4.99 
 Immune defect disorder 44 4.22 
 Lipid processing and storage disorders 37 3.55 
 Lipodystrophy 33 3.16 
 Chronic Graft Versus Host Disease 33 3.16 
Comorbidities None 921 88.30 
 Present 122 11.70 
Continuous Variables 
Characteristic Mean Standard deviation Minimum Maximum 
Age (years) 38.95 12.43 18.00 79.00 
25-OH Vitamin D (ng/mL) 24.61 11.84 1.00 88.00 
CRP (mg/dL) 0.87 1.82 0.01 33.60 





Table 2. Results of Unadjusted and Adjusted Analysis 
 Unadjusted analysis Adjusted analysis* 
 β  p-value 95% CI β  p-value 95% CI 
CRP -0.47 0.02 (-0.86, -0.07) -0.39 0.04 (-0.77, -0.02) 
Race 
  Black  -9.68 <0.0001 (-6.54, 0.55) -8.79 <0.0001 (-10.62, -6.96) 
  Hispanic  
  or Latino 
-5.05 0.0005 (-2.53, 5.80) -5.27 0.0002 (-8.09, -2.46) 
  Other -6.69 <0.0001 (3.44, 9.93) -7.16 <0.0001 (-10.36, -3.96) 
  White - - - - - - 
Multivitamin 
  Taking 3.24 0.0007 (1.37, 5.12) 2.59 0.01 (0.81, 4.37) 
  Not taking - - - - - - 
BMI -0.32 <0.0001 (-0.42, -0.22) -0.23 <0.0001 (-0.33, -0.13) 
*Adjusted for race, multivitamin supplementation and BMI.  
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Appendix A. Table Illustrating Diagnoses Included in Each Category 
 Category Class of diagnosis Included 
0 Lipodystrophy  
1 Auto-immune 
diseases 
Systemic lupus erythematosus; rheumatoid arthritis; polyarthritis; 
osteoarthritis; synovitis; Sarcoidosis; arthropathy; pyoderma 
gangrenosum and acne syndrome (PAPA); crohn’s disease 
2 Normal volunteer  
3 Turner syndrome  
4 Immune defect 
disorder 
Chronic granulomatous disease; Job’s  









7 Other Gland or hormone disorders [thyroid dysfunction; 
hyperparathyroidism; adrenal gland neoplasm; pheochromoctoma; 
insulin resistance]; non-autoimmune-associated pain disorders 
[dermamyositis; polymyositis; fibromyalgia; myositis; unspecified 
disorder of autonomic nervous system; erythromelalgia; carpal 
tunnel]; Acute infection or recurrent febrile disease [familial 
Mediterranean fever]; disorders of the bone marrow [diamond-
blackfan anemia; sickle cell; dyskeratosis congenita]; cancer [T-cell 
lymphoma; ewing's sarcoma; primary brain tumor-glioblastoma; 
chronic myelogenous leukemia; malignant neoplasm of kidney; 
hodgkins lymphoma; acute promyelocitic leukemia; acute 
myelogenous leukemia; large B-cell lymphoma; multiple myeloma; 
breast cancer; prostate cancer; peripheral T-cell lymphoma; chronic 
lymphocytic leukemia; recurrent refractory mantel cell lymphoma; 
chronic lymphocytic leukemia, chronic lymphocytic; non-hodgkin's 
lymphoma; myelodysplasia]; chronic lung disease 
[lymphangioleiomyomatosis; cystic fibrosis]; hemochromatosis; 
hepatic fibrosis; kidney disease; osler-weber-rendu syndrome; 
erdheim-chester disease 
8 Lipid processing 
and storage 
disorders 
 Fabry-anderson disease; gaucher disease; homozygous familial 
hypercholesterolemia; lipoprotein deficiencies-abetalipoproteinemia; 
lecithin cholesterol acyltransferase deficiency; homozygous 
hypobetalipoproteinemia; homozygous hypobetalipoproteinemia; 
sitosterolemia 
9 cGVHD  
10  Disturbances of 
amino acid 
metabolism 
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